Patents by Inventor Toshimori Inaba

Toshimori Inaba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicinal composition for treating arteriosclerosis
    Publication number: 20050192245
    Abstract: A medicinal composition, wherein an ADP receptor antagonist and an ACAT inhibitor are administered either simultaneously or separately at a defined interval as a preventive or a remedy (in particular, a remedy) for arteriosclerosis or diseases derived from arteriosclerosis such as ischemic heart disease, ischemic brain disease and peripheral circulation failure in warm-blooded animals (in particular, humans).
    Type: Application
    Filed: January 18, 2005
    Publication date: September 1, 2005
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Fumitoshi Asai, Toshimori Inaba, Taketoshi Ogawa
  • Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
    Publication number: 20050119314
    Abstract: The present invention provides a pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent as effective components for the prevention or therapy against atherosclerosis or diseases caused by atherosclerosis.
    Type: Application
    Filed: September 30, 2004
    Publication date: June 2, 2005
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Toshimori Inaba, Toshihiko Fujiwara
  • Medicinal compositions containing angiotensin II receptor antagonist
    Publication number: 20040198788
    Abstract: A pharmaceutical composition for administering an angiotensin II receptor antagonist and an ACAT inhibitor. A method for preventing or treating arteriosclerosis or ischemic heart disease.
    Type: Application
    Filed: February 26, 2004
    Publication date: October 7, 2004
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Toshio Sada, Toshimori Inaba
  • Pharmaceutical composition
    Publication number: 20040092571
    Abstract: The present invention provides a pharmaceutical composition for administering simultaneously, separately or sequentially N-(1-octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide or a pharmacologically acceptable salt thereof, and a HMG-CoA reductase inhibitor. The composition has an excellent lipid lowering action and excellent progress inhibitory effects on atherosclerosis, has excellent progress inhibitory effects on atherosclerosis in the aorta, has excellent onset inhibitory effects on xanthoma occurring in limb joints, and is useful as a preventive or therapeutic agent for atherosclerosis or xanthoma.
    Type: Application
    Filed: November 5, 2003
    Publication date: May 13, 2004
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Takafumi Kohama, Toshimori Inaba
  • Pharmaceutical composition
    Publication number: 20020055533
    Abstract: The present invention provides a pharmaceutical composition for administering simultaneously, separately or sequentially N-(1-octyl-5-carboxymethyl-4, 6-dimethylindolin-7-yl)-2,2-dimethylpropanamide or a pharmacologically acceptable salt thereof, and a HMG-COA reductase inhibitor. The composition has an excellent lipid lowering action and excellent progress inhibitory effects on atherosclerosis, has excellent progress inhibitory effects on atherosclerosis in the aorta, has excellent onset inhibitory effects on xanthoma occurring in limb joints, and is useful as a preventive or therapeutic agent for atherosclerosis or xanthoma.
    Type: Application
    Filed: August 31, 2001
    Publication date: May 9, 2002
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Takafumi Kohama, Toshimori Inaba